The company runningtheexperiment, VaxInnate, a closely held biotech firm, is working on technology that could derive in only six weeks a new vaccine for the H1N1 swine flu, the virus causing the global scare.
So it may be no surprise to learn that although the staff have some catching up to do the week after theexperiment, therunning of the company doesn't appear to have been affected.